<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>pädiatrie | Das Blog</title>
    <link>/tag/padiatrie/</link>
      <atom:link href="/tag/padiatrie/index.xml" rel="self" type="application/rss+xml" />
    <description>pädiatrie</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 19 Nov 2015 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/media/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_3.png</url>
      <title>pädiatrie</title>
      <link>/tag/padiatrie/</link>
    </image>
    
    <item>
      <title>Endlich ein Gegenmittel zur Kurzsichtigkeit!? ...</title>
      <link>/post/2015-11-19-endlich-ein-gegenmittel-zur-kurzsichtigkeit/</link>
      <pubDate>Thu, 19 Nov 2015 00:00:00 +0000</pubDate>
      <guid>/post/2015-11-19-endlich-ein-gegenmittel-zur-kurzsichtigkeit/</guid>
      <description>&lt;p&gt;Endlich ein Gegenmittel zur Kurzsichtigkeit!?&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&lt;a href=&#34;http://www.sciencedaily.com/releases/2015/11/151116212649.htm&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;















&lt;figure  &gt;
  &lt;div class=&#34;d-flex justify-content-center&#34;&gt;
    &lt;div class=&#34;w-100&#34; &gt;&lt;img src=&#34;https://www.sciencedaily.com/images/scidaily-icon.png&#34; alt=&#34;&#34; loading=&#34;lazy&#34; data-zoomable /&gt;&lt;/div&gt;
  &lt;/div&gt;&lt;/figure&gt;
&lt;/a&gt;
sciencedaily.com&lt;/p&gt;
&lt;h2 id=&#34;nearsightedness-progression-in-children-slowed-down-by-medicated-eye-dropshttpwwwsciencedailycomreleases201511151116212649htm&#34;&gt;&lt;a href=&#34;http://www.sciencedaily.com/releases/2015/11/151116212649.htm&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Nearsightedness progression in children slowed down by medicated eye drops&lt;/a&gt;&lt;/h2&gt;
&lt;p&gt;Atropine .01 percent eye drops slow down nearsightedness by roughly 50 percent in five-year clinical trial on Singaporean children. Researchers suggest low-dose drops safe as &amp;lsquo;first line&amp;rsquo; defense against rapid development of nearsightedness in children.&lt;/p&gt;
&lt;/blockquote&gt;
</description>
    </item>
    
  </channel>
</rss>
